Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04304417
Other study ID # 2019/20-020
Secondary ID
Status Completed
Phase
First received
Last updated
Start date February 17, 2020
Est. completion date April 1, 2022

Study information

Verified date May 2022
Source Universidad Complutense de Madrid
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This study analyzes which variables enhance or hinder community integration among people with severe mental disorder. Participants will complete a questionnaire to test our hypotheses: - Hypothesis 1: group identification predicts less self-dehumanization and self-stigma, and more empowerment, these in turn predict more community integration. - Hypothesis 2: the relationship between group identification and self-dehumanization and self-stigma is moderated by group value. - Hypothesis 3: when group identification is low, group identification predicts higher community integration, but this relationship is mediated by diagnosis concealment.


Description:

Community integration, which includes physical integration (e.g. participation in activities, as well as use of goods and services in the community in a self-initiated manner), social integration (e.g. quantity and quality of social relationships) and psychological integration (e.g. perception of belongingness to the community), is a necessary element to achieve personal recovery among people with severe mental disorder (SMD). Group identification, based on Social Identity Theory, emphasizes an individual's definition of who they are in relation to their group membership. When individuals have a strong tendency to define their self-concept in terms of the group they belong to and uphold the values of their group, they are said to have high identification with the group. Group value, on the other hand, refers to the evaluative judgment of one's social group, which reflects the extent to which individuals feel positively or negatively toward their ingroup, and people who have positive perceptions toward their group are more strongly identified with it. Self-dehumanization is the process by which people dehumanize themselves. This can happen in two ways: when they perceiving themselves as unintelligent, amoral, irrational, wild, etc.; thus perceived as animal-like, it is called animalistic dehumanization; or when they perceive themselves as lacking emotion, warmth, vitality, etc.; perceived as object-like, which is referred to as mechanistic dehumanization. Self-stigma occurs when people accept the negative stereotypes about their in-group apply to themselves. This has shown to influence the community integration of people with SMD. Empowerment is understood as the process by which people, organizations and communities acquire control over their own lives. People with SMD who endorsed higher group value were more likely to be involved in educating the public about mental health and helping others with mental disorder, which are considered a behavioral manifestation of empowerment. In order to test the hypotheses previously mentioned, the users of the public centers of social care for people with SMD of the State of Madrid (Spain) will be contacted. The inclusion criteria are: to have a diagnosis of SMD and disorder consciousness. The exclusion criteria are: to be underage and legally incapacitated. Participants will complete a pencil-and-paper questionnaire, including the measurement of the variables previously mentioned and some socio-demographical questions, in the centers they attend. The analytical program SPSS.25 (Statistical Package for the Social Sciences) will be used to conduct the appropriate test of hypothesis (correlation, regression, mediation, moderation).


Recruitment information / eligibility

Status Completed
Enrollment 70
Est. completion date April 1, 2022
Est. primary completion date April 1, 2022
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Having a diagnosis of severe mental disorder. - Having disorder consciousness. Exclusion Criteria: - Being underage. - Being legally incapacitated.

Study Design


Locations

Country Name City State
Spain Grupo 5 Madrid State Of Madrid

Sponsors (1)

Lead Sponsor Collaborator
Universidad Complutense de Madrid

Country where clinical trial is conducted

Spain, 

Outcome

Type Measure Description Time frame Safety issue
Primary Physical integration Self-reported frequency of activities realized outdoors, measured with the subscale 'Leisure and community' from the 'Independent living skills survey'. Each item is scored from 1 (never) to 5 (always). 1 day. Measured the day of the study.
Primary Social integration Self-reported frequency of support available, measured with the Medical Outcome Study Social Support Survey (MOS-SSS). Each item is scored from 1 (never) to 5 (always). 1 day. Measured the day of the study.
Primary Psychological integration Self-reported feeling of belonging to the general community and to the community of people with mental disorder. It is measured with the subscale 'Belonging' from the 'Community Integration Measure'. Each item is scored from 1 (I totally disagree) to 5 (I totally agree). 1 day. Measured the day of the study.
Secondary Self-dehumanization Haslam's scale of Human Nature and Human Uniqueness to measure wether participants think different adjectives describe them. Each item is scored from 1 (I am not at all like that) to 7 (I am exactly like that). 1 day. Measured the day of the study.
Secondary Self-stigma Self-reported measure of participants' internalized stigma using the 'Internalized Stigma of Mental Illness Inventory-9'. Each item range from 1 (I totally disagree) to 4 (I totally agree). 1 day. Measured the day of the study.
Secondary Empowerment Self-reported measure of empowerment using the subscales 'Self-esteem-self-efficacy' and 'Community activism and autonomy' from the empowerment scale developed by Rogers, Chamberlin, Ellison y Crean (1997), and the subscale 'disclosure' developed by King et al. (2007). Items range from 1 (I totally disagree) to 4 (I totally agree). 1 day. Measured the day of the study.
Secondary Group identity The subscales 'Interconnection of self with the group' and 'Sense of interdependence' from the team identity scale developed by Heere and James (2007). Items range from 1 (I totally disagree) to 7 (I totally agree). 1 day. Measured the day of the study.
Secondary Group value The subscale 'Private evaluation' from the team identity scale developed by Heere and James (2007). Items range from 1 (I totally disagree) to 7 (I totally agree). 1 day. Measured the day of the study.
See also
  Status Clinical Trial Phase
Completed NCT05111548 - Brain Stimulation and Cognitive Training - Efficacy N/A
Completed NCT02855762 - Targeting the Microbiome to Improve Clinical Outcomes in Bipolar Disorder N/A
Recruiting NCT05915013 - Alpha-Amino-3-Hydroxy-5-Methyl-4- Isoxazole Propionic Acid Receptor Components of the Anti-Depressant Ketamine Response Phase 1
Recruiting NCT05206747 - Ottawa Sunglasses at Night for Mania Study N/A
Completed NCT02513654 - Pharmacokinetics, Safety and Tolerability of Repeat Dosing Lamotrigine in Healthy Chinese Subjects Phase 1
Recruiting NCT06313918 - Exercise Therapy in Mental Disorders-study N/A
Completed NCT02304432 - Targeting a Genetic Mutation in Glycine Metabolism With D-cycloserine Early Phase 1
Recruiting NCT06197048 - Effect of Nutritional Counseling on Anthropometry and Biomarkers in Patients Diagnosed With Schizophrenia/Psychosis or Bipolar Affective Disorder N/A
Completed NCT03497663 - VIA Family - Family Based Early Intervention Versus Treatment as Usual N/A
Completed NCT04284813 - Families With Substance Use and Psychosis: A Pilot Study N/A
Completed NCT02212041 - Electronic Cigarettes in Smokers With Mental Illness N/A
Recruiting NCT05030272 - Comparing Two Behavioral Approaches to Quitting Smoking in Mental Health Settings N/A
Recruiting NCT04298450 - ED to EPI: Using SMS to Improve the Transition From the Emergency Department to Early Psychosis Intervention N/A
Active, not recruiting NCT03641300 - Efficacy of Convulsive Therapies for Bipolar Depression N/A
Not yet recruiting NCT04432116 - Time and Virtual Reality in Schizophrenia and Bipolar Disorder N/A
Completed NCT02970721 - Use of Psychotropic Medications Among Pregnant Women With Bipolar Disorder
Terminated NCT02893371 - Longitudinal Comparative Effectiveness of Bipolar Disorder Therapies
Terminated NCT02909504 - Gao NARASD Lithium Study Phase 4
Recruiting NCT02481245 - BezafibrateTreatment for Bipolar Depression: A Proof of Concept Study Phase 2
Recruiting NCT03088657 - Design and Methods of the Mood Disorder Cohort Research Consortium (MDCRC) Study